Madalena Almeida Borges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Madalena Almeida Borges has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Margarida Abranches
Hospital Dona Estefânia, Portugal
3 shared publications - Telma Francisco
Hospital Dona Estefânia, Portugal
3 shared publications - Fernando Caeiro
Hospital Curry Cabral, Portugal
2 shared publications - Gisela Neto
Hospital Dona Estefânia, Portugal
2 shared publications - Gonçalo Vale
Hospital Dona Estefânia, Portugal
2 shared publications - Helena Sousa
Hospital Curry Cabral, Portugal
2 shared publications
Latest Publications
- Open Access
- 1 September 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (3) , e20240260
Comparison of real-world kidney outcomes with predicted outcomes at the time of diagnosis and post-biopsy in a cohort of children with IgA nephropathy
Introduction: IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis, with a variable clinical course. This study aimed to evaluate real-world kidney outcomes in children with IgAN and compare these with predictions from the International IgAN Prediction Tool for children (IIgAN-PT). Methods: A single-center, longitudinal retrospective study was conducted on pediatric patients diagnosed with IgAN from 2010 to 2022. Data on clinical, laboratory, and histological parameters were analyzed. The IIgAN-PT score was calculated for each patient at biopsy and one year after biopsy. The primary outcome was a composite endpoint of ≥30% eGFR decrease or progression to end stage kidney disease (ESKD). Results: Among 23 patients (57% male, median age at biopsy 13.8 years), MEST-C scores showed M1 in 87%, E1 in 22%, S1 in 39%, T1/2 in 13%, and C1 in 26%. During a median 3.1-year follow-up, 26% reached the primary outcome, while the median predicted risk based on IIgAN-PT was 6.5%. Additionally, 57% experienced eGFR decline (annual median decline of 5.6 mL/min/1.73 m2). Application of the updated IIgAN-PT one-year post-biopsy (n = 13) resulted in a median predicted risk of 1.79%, while 23% met the primary outcome. Conclusion: The observed eGFR decline or progression to ESKD was higher than predicted, highlighting the need for early diagnosis, monitoring, and treatment. Small-scale studies like ours underscore the importance of early intervention and may inform the design of larger studies to improve the predictive ability of the IIgAN-PT tool in diverse clinical settings.
- 1 September 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (3) , e20240260
Open AccessComparison of real-world kidney outcomes with predicted outcomes at the time of diagnosis and post-biopsy in a cohort of children with IgA nephropathy
Introduction: IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis, with a variable clinical course. This study aimed to evaluate real-world kidney outcomes in children with IgAN and compare these with predictions from the International IgAN Prediction Tool for children (IIgAN-PT). Methods: A single-center, longitudinal retrospective study was conducted on pediatric patients diagnosed with IgAN from 2010 to 2022. Data on clinical, laboratory, and histological parameters were analyzed. The IIgAN-PT score was calculated for each patient at biopsy and one year after biopsy. The primary outcome was a composite endpoint of ≥30% eGFR decrease or progression to end stage kidney disease (ESKD). Results: Among 23 patients (57% male, median age at biopsy 13.8 years), MEST-C scores showed M1 in 87%, E1 in 22%, S1 in 39%, T1/2 in 13%, and C1 in 26%. During a median 3.1-year follow-up, 26% reached the primary outcome, while the median predicted risk based on IIgAN-PT was 6.5%. Additionally, 57% experienced eGFR decline (annual median decline of 5.6 mL/min/1.73 m2). Application of the updated IIgAN-PT one-year post-biopsy (n = 13) resulted in a median predicted risk of 1.79%, while 23% met the primary outcome. Conclusion: The observed eGFR decline or progression to ESKD was higher than predicted, highlighting the need for early diagnosis, monitoring, and treatment. Small-scale studies like ours underscore the importance of early intervention and may inform the design of larger studies to improve the predictive ability of the IIgAN-PT tool in diverse clinical settings.
- Open Access
- 1 September 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (3)
Comparação de desfechos renais de mundo real com desfechos previstos no momento do diagnóstico e pós-biópsia em uma coorte de crianças com nefropatia por IgA
Resumo Introdução: Nefropatia por IgA (NIgA) é a forma mais comum de glomerulonefrite primária, apresentando curso clínico variável. Este estudo teve como objetivo avaliar desfechos renais de mundo real em crianças com NIgA e compará-los com previsões da International IgAN Prediction Tool (IIgAN-PT) para crianças. Métodos: Realizou-se estudo retrospectivo longitudinal de centro único em pacientes pediátricos diagnosticados com NIgA de 2010-2022. Foram analisados dados sobre parâmetros clínicos, laboratoriais e histológicos. O escore IIgAN-PT foi calculado para cada paciente na biópsia e um ano pós-biópsia. O desfecho primário foi um desfecho composto de redução ≥30% da TFGe ou progressão para doença renal em estágio terminal (DRET). Resultados: Entre 23 pacientes (57% do sexo masculino , idade mediana na biópsia 13,8 anos), os escores MEST-C demonstraram M1 em 87%, E1 em 22%, S1 em 39%, T1/2 em 13% e C1 em 26%. Durante acompanhamento mediano de 3,1 anos, 26% atingiram o desfecho primário, enquanto o risco mediano previsto com base no IIgAN-PT foi 6,5%. Além disso, 57% apresentaram declínio da TFGe (declínio anual mediano de 5,6 mL/min/1,73 m2). A aplicação do IIgAN-PT atualizado um ano pós-biópsia (n = 13) resultou em risco mediano previsto de 1,79%, enquanto 23% atingiram o desfecho primário. Conclusão: O declínio observado da TFGe ou progressão para DRET foi maior que o previsto, destacando a necessidade de diagnóstico, monitoramento e tratamento precoces. Estudos de pequena escala, como o nosso, ressaltam a importância da intervenção precoce e podem orientar o desenho de estudos maiores para aprimorar a capacidade preditiva da ferramenta IIgAN-PT em diversos cenários clínicos.
- 1 September 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (3)
Open AccessComparação de desfechos renais de mundo real com desfechos previstos no momento do diagnóstico e pós-biópsia em uma coorte de crianças com nefropatia por IgA
Resumo Introdução: Nefropatia por IgA (NIgA) é a forma mais comum de glomerulonefrite primária, apresentando curso clínico variável. Este estudo teve como objetivo avaliar desfechos renais de mundo real em crianças com NIgA e compará-los com previsões da International IgAN Prediction Tool (IIgAN-PT) para crianças. Métodos: Realizou-se estudo retrospectivo longitudinal de centro único em pacientes pediátricos diagnosticados com NIgA de 2010-2022. Foram analisados dados sobre parâmetros clínicos, laboratoriais e histológicos. O escore IIgAN-PT foi calculado para cada paciente na biópsia e um ano pós-biópsia. O desfecho primário foi um desfecho composto de redução ≥30% da TFGe ou progressão para doença renal em estágio terminal (DRET). Resultados: Entre 23 pacientes (57% do sexo masculino , idade mediana na biópsia 13,8 anos), os escores MEST-C demonstraram M1 em 87%, E1 em 22%, S1 em 39%, T1/2 em 13% e C1 em 26%. Durante acompanhamento mediano de 3,1 anos, 26% atingiram o desfecho primário, enquanto o risco mediano previsto com base no IIgAN-PT foi 6,5%. Além disso, 57% apresentaram declínio da TFGe (declínio anual mediano de 5,6 mL/min/1,73 m2). A aplicação do IIgAN-PT atualizado um ano pós-biópsia (n = 13) resultou em risco mediano previsto de 1,79%, enquanto 23% atingiram o desfecho primário. Conclusão: O declínio observado da TFGe ou progressão para DRET foi maior que o previsto, destacando a necessidade de diagnóstico, monitoramento e tratamento precoces. Estudos de pequena escala, como o nosso, ressaltam a importância da intervenção precoce e podem orientar o desenho de estudos maiores para aprimorar a capacidade preditiva da ferramenta IIgAN-PT em diversos cenários clínicos.
- 28 March 2023
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 37 (1)
Primary Hyperoxaluria Type 1: The First Patient Treated with Lumasiran in Portugal
Primary hyperoxaluria type 1 is a rare genetic disease caused by mutations in AGXT, leading to an excessive hepatic production of oxalate, resulting in urolithiasis, nephrocalcinosis and chronic kidney disease. The authors present the case of a young female with PH1 who is the first patient treated with lumasiran in Portugal, and currently has a follow-up of 18 months.
- 28 March 2023
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 37 (1)
Primary Hyperoxaluria Type 1: The First Patient Treated with Lumasiran in Portugal
Primary hyperoxaluria type 1 is a rare genetic disease caused by mutations in AGXT, leading to an excessive hepatic production of oxalate, resulting in urolithiasis, nephrocalcinosis and chronic kidney disease. The authors present the case of a young female with PH1 who is the first patient treated with lumasiran in Portugal, and currently has a follow-up of 18 months.
- 1 January 2023
- Published by Pediatric Oncall Pvt Ltd in Pediatric Oncall
- Vol. 20 (3)
A case of severe X-linked hypophosphatemia caused by a novel PHEX mutation
Read about a case of severe X-linked hypophosphatemia caused by a novel PHEX mutation.
- 1 January 2023
- Published by Pediatric Oncall Pvt Ltd in Pediatric Oncall
- Vol. 20 (3)
A case of severe X-linked hypophosphatemia caused by a novel PHEX mutation
Read about a case of severe X-linked hypophosphatemia caused by a novel PHEX mutation.
- 19 October 2022
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (3) , 151
Sickle Cell Disease Diagnosis Uncovered by Incidental Radiograph Findings
- 19 October 2022
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (3) , 151
Sickle Cell Disease Diagnosis Uncovered by Incidental Radiograph Findings
- 2 May 2022
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 35 (5) , 367-375
Tuberculose em Idade Pediátrica: Experiência de 12 Anos num Centro Terciário de Referência em Portugal
Introduction: The diagnosis of tuberculosis in children is a challenge namely because extrapulmonary tuberculosis and severe disease are more frequent in this age group. The aim of this study was to evaluate and reflect about severe tuberculosis in pediatric age, in a metropolitan area of Lisbon. Material and Methods: Descriptive study about patients under 18 years of age admitted with tuberculosis disease in a tertiary pediatric hospital, from 2008 to 2019 (12 years). Results: We report 145 patients, average of 12 cases/year, with an increase in the last three years. Median age of 12.9 years, 42.8% born in Portuguese-speaking African countries and 20% had a chronic disease. The diagnosis was pulmonary tuberculosis in 52.4% (n = 76) and extrapulmonary tuberculosis in 47.6%: lymphatic (n = 26), skeletal (n = 15), miliary (n = 8), meningeal (n = 7), peritoneal/ intestinal (n = 6), pleural (n = 4), renal (n = 1), cutaneous (n = 1), thoracic wall (n = 1) and salivary glands (n = 1). The tuberculin test was positive in 78/99 (78.8%) and Interferon Gamma Release Assay in 61/90 (67.8%). In 20.7% (n = 30) acid-fast bacilli were identified in gastric aspirate/sputum and the agent was identified in 59.3% (n = 86). Tuberculosis was resistant in 11% (n = 16). Patients with extrapulmonary tuberculosis were younger (p = 0.006) and had more prolonged therapy (p < 0.001). Therapy-related complications occurred in 11% (n = 16). One patient died (with terminal cancer). Conclusion: This study highlights the need for screening of tuberculosis in children from endemic countries, patients with immunosuppression and chronic disease.
- 2 May 2022
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 35 (5) , 367-375
Tuberculose em Idade Pediátrica: Experiência de 12 Anos num Centro Terciário de Referência em Portugal
Introduction: The diagnosis of tuberculosis in children is a challenge namely because extrapulmonary tuberculosis and severe disease are more frequent in this age group. The aim of this study was to evaluate and reflect about severe tuberculosis in pediatric age, in a metropolitan area of Lisbon. Material and Methods: Descriptive study about patients under 18 years of age admitted with tuberculosis disease in a tertiary pediatric hospital, from 2008 to 2019 (12 years). Results: We report 145 patients, average of 12 cases/year, with an increase in the last three years. Median age of 12.9 years, 42.8% born in Portuguese-speaking African countries and 20% had a chronic disease. The diagnosis was pulmonary tuberculosis in 52.4% (n = 76) and extrapulmonary tuberculosis in 47.6%: lymphatic (n = 26), skeletal (n = 15), miliary (n = 8), meningeal (n = 7), peritoneal/ intestinal (n = 6), pleural (n = 4), renal (n = 1), cutaneous (n = 1), thoracic wall (n = 1) and salivary glands (n = 1). The tuberculin test was positive in 78/99 (78.8%) and Interferon Gamma Release Assay in 61/90 (67.8%). In 20.7% (n = 30) acid-fast bacilli were identified in gastric aspirate/sputum and the agent was identified in 59.3% (n = 86). Tuberculosis was resistant in 11% (n = 16). Patients with extrapulmonary tuberculosis were younger (p = 0.006) and had more prolonged therapy (p < 0.001). Therapy-related complications occurred in 11% (n = 16). One patient died (with terminal cancer). Conclusion: This study highlights the need for screening of tuberculosis in children from endemic countries, patients with immunosuppression and chronic disease.
- 2 March 2021
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 40 (6) , e247-e249
Kingella kingae
Kingella kingae is the leading cause of osteoarticular infections between 6 and 48 months, a well-known cause of pediatric bacteremia and endocarditis and has been rarely associated with meningitis. We report a case of a healthy 10-year-old boy with meningitis due to Kingella kingae who presented with a history of severe headache, vomiting and prostration.
- 2 March 2021
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 40 (6) , e247-e249
Kingella kingae
Kingella kingae is the leading cause of osteoarticular infections between 6 and 48 months, a well-known cause of pediatric bacteremia and endocarditis and has been rarely associated with meningitis. We report a case of a healthy 10-year-old boy with meningitis due to Kingella kingae who presented with a history of severe headache, vomiting and prostration.